Scinai Immunotherapeutics Ltd ADR (NQ: SCNI )
2.970
-1.180
(-28.43%)
Streaming Delayed Price
Updated: 3:57 PM EDT, Jun 7, 2024
Add to My Watchlist
Press Releases about Scinai Immunotherapeutics Ltd ADR
NIH Researchers Unveil AI Tool to Predict Oncology Patients’ Response to Immunotherapy
Today 11:05 EDT
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Autoimmunity Patients Face Cost, Diagnosis, Care Challenges
November 28, 2023
New, Deadly Infectious Diseases Could Emerge as Climate Change Worsens
November 14, 2023
Topics
Climate Change
Exposures
Climate
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receive $900K IIA Grant for New CDMO Business Unit
November 07, 2023
Topics
Economy
Exposures
Economy
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.